glp-1 receptor agonist kidney outcomes semaglutide flow trial 2024 results Ozempic® (semaglutide injection) GLP-1 receptor agonists in patients

[DOI] [PMC free article] [PubMed] [Google Scholar] 82.Abdali D., Samson S.E., Grover A.K

The side effect comparison between the two also helps clarify their risk profiles

People with type 2 diabetes using GLP-1 receptor agonists, DPP-IV inhibitors or multiple therapies combining metformin, sulfonylureas, repaglinide, alpha-glucosidase inhibitors or thiazolidinediones from 2006 to 2018 were included

Both GLP-1 receptor agonists and metformin are commonly used to manage insulin resistance , but they work in different ways

For example, in a previous study, teneligliptin ameliorated hypertension and comorbid cardiac remodeling in SHR by attenuating circulating AngII ( + retention, thus enhancing Na + /Ca 2+ exchange and H 2 O reabsorption ( In addition, ACE inactivates substance P via the carboxy terminus